{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:01:33Z","timestamp":1769104893229,"version":"3.49.0"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.7293","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T15:00:53Z","timestamp":1649948453000},"page":"e227293","source":"Crossref","is-referenced-by-count":31,"title":["Association of Septal Myectomy With Quality of Life in Patients With Left Ventricular Outflow Tract Obstruction From Hypertrophic Cardiomyopathy"],"prefix":"10.1001","volume":"5","author":[{"given":"Milind Y.","family":"Desai","sequence":"first","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albree","family":"Tower-Rader","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio"},{"name":"Department of Cardiovascular Medicine, Massachusetts General Hospital, Boston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Szpakowski","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amgad","family":"Mentias","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran B.","family":"Popovic","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas G.","family":"Smedira","sequence":"additional","affiliation":[{"name":"The Hypertrophic Cardiomyopathy Center, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","published-online":{"date-parts":[[2022,4,14]]},"reference":[{"issue":"3","key":"zld220059r1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.112.000849","article-title":"Predictors of long-term outcomes in symptomatic hypertrophic obstructive cardiomyopathy patients undergoing surgical relief of left ventricular outflow tract obstruction.","volume":"128","author":"Desai","year":"2013","journal-title":"Circulation"},{"issue":"25","key":"zld220059r2","doi-asserted-by":"publisher","first-page":"e159","DOI":"10.1016\/j.jacc.2020.08.045","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"76","author":"Ommen","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"zld220059r3","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review.","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"zld220059r4","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.jacc.2019.09.007","article-title":"Health status after transcatheter versus surgical aortic valve replacement in low-risk patients with aortic stenosis.","volume":"74","author":"Baron","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"zld220059r5","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.jacc.2019.02.010","article-title":"Health status after transcatheter mitral-valve repair in heart failure and secondary mitral regurgitation: COAPT Trial.","volume":"73","author":"Arnold","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"10293","key":"zld220059r6","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/S0140-6736(21)00763-7","article-title":"Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.","volume":"397","author":"Spertus","year":"2021","journal-title":"Lancet"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2791040\/desai_2022_ld_220059_1649278372.20497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T15:00:56Z","timestamp":1649948456000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2791040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,14]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.7293","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,14]]}}}